Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.8500
-0.0038 (-0.45%)
At close: Nov 20, 2025, 4:00 PM EST
0.8500
0.00 (0.00%)
After-hours: Nov 20, 2025, 4:10 PM EST
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $5.04 million as of November 20, 2025. Its market cap has increased by 261.34% in one year.
Market Cap
5.04M
Enterprise Value
-7.65M
1-Year Change
261.34%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $5.04M, a decrease of -94.44%. That is a compound annual growth rate of -43.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 5.06M | 31.30% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.38% |
| Dec 30, 2022 | 4.46M | -93.27% |
| Dec 31, 2021 | 66.32M | -28.84% |
| Dec 31, 2020 | 93.20M | 2.97% |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 939.79B |
| Johnson & Johnson | 487.91B |
| AbbVie | 411.64B |
| UnitedHealth Group | 279.99B |
| AstraZeneca | 275.69B |
| Novartis AG | 243.58B |
| Merck & Co. | 235.92B |
| Abbott Laboratories | 219.36B |